Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Skin reactions from cancer treatments might predict how well the treatments work.

Nivolumab can cause hair loss as a rare side effect.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Pantethine may boost the immune system's ability to fight sarcoma.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Immune cells are essential for early hair and skin development and healing.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.